Triglycerides, Medium Chain

This article examines several clinical trials investigating the use of medium chain triglycerides (MCTs) in different medical scenarios. MCTs are a type of fat that is more easily digested and absorbed by the body compared to long chain triglycerides. These trials explore how MCTs may benefit patients undergoing major abdominal surgery, those on hemodialysis, and premature infants with respiratory distress syndrome. The studies aim to evaluate the effects of MCTs on nutrition, muscle preservation, toxin removal, and sedation in these diverse patient populations.

Table of Contents

What are Medium Chain Triglycerides (MCTs)?

Medium Chain Triglycerides, commonly known as MCTs, are a type of fat with unique properties that make them valuable in medical treatments. MCTs are composed of fatty acids with a chain length of 6 to 12 carbon atoms[1]. They are different from long-chain triglycerides (LCTs) found in most dietary fats because they are more easily absorbed and metabolized by the body.

MCTs are often derived from vegetable sources and can be found in products like coconut oil and palm kernel oil. In medical settings, they are usually administered as part of specialized nutritional formulations.

Medical Uses of MCTs

Medium Chain Triglycerides have several important medical applications:

  • Parenteral Nutrition: MCTs are a key component in parenteral nutrition formulations, which are used to provide nutrition to patients who cannot eat by mouth. These formulations, such as SmofKabiven and Medialipide, contain MCTs along with other nutrients to support patients’ nutritional needs[2].
  • Malabsorption Disorders: MCTs can be beneficial for patients with conditions that affect fat absorption, such as pancreatic insufficiency or short bowel syndrome. The shorter chain length of MCTs allows for easier absorption in the intestines.
  • Ketogenic Diets: MCTs are sometimes used in ketogenic diets for epilepsy management, as they can be converted to ketones more easily than other fats.
  • Cachexia: In some cases, MCTs may be used to help combat cachexia, a condition of extreme weight loss and muscle wasting often associated with chronic diseases.

Benefits of MCTs

The unique properties of Medium Chain Triglycerides offer several benefits in medical treatments:

  • Rapid Energy Source: MCTs are quickly absorbed and metabolized, providing a rapid source of energy for patients who may have difficulty processing other types of fats.
  • Improved Nutrient Absorption: In patients with malabsorption issues, MCTs can help improve the absorption of fat-soluble vitamins and other nutrients.
  • Reduced Fat Storage: Unlike long-chain triglycerides, MCTs are less likely to be stored as body fat, which can be beneficial for patients at risk of excessive weight gain.
  • Ketone Production: MCTs can be converted to ketones, which may provide an alternative energy source for the brain and other organs.

Administration and Dosage

MCTs are typically administered as part of specialized nutritional formulations. In clinical settings, they may be given through intravenous infusion. For example, in one study, patients received an intravenous infusion of 0.11 g lipid/kg/hour of a 20% MCT emulsion during a 4-hour hemodialysis session[1].

The dosage and administration method can vary depending on the specific medical condition and the patient’s needs. It’s crucial that MCT administration is overseen by healthcare professionals to ensure proper dosing and monitoring.

Potential Side Effects and Precautions

While MCTs are generally well-tolerated, there are some potential side effects and precautions to be aware of:

  • Gastrointestinal Distress: Some patients may experience nausea, vomiting, or diarrhea, especially when MCTs are first introduced.
  • Allergic Reactions: Patients with allergies to coconut, palm kernel, or soy products should use MCT products with caution.
  • Liver Function: In patients with liver disease, MCT metabolism may be affected, requiring careful monitoring.
  • Ketoacidosis Risk: In rare cases, excessive use of MCTs could potentially lead to ketoacidosis, particularly in patients with diabetes.

It’s important to note that MCT administration should always be under medical supervision, especially in clinical settings such as during hemodialysis or parenteral nutrition.

Ongoing Research

Research into the medical applications of MCTs is ongoing. Current studies are exploring their potential benefits in various areas:

  • Hemodialysis: One study is investigating whether infusion of MCTs during hemodialysis can improve the clearance of certain toxins in patients with chronic kidney disease[1].
  • Muscle Wasting: Another study is examining how the route of nutrition, including MCT-containing formulations, affects muscle wasting in patients recovering from esophageal surgery[3].
  • Neonatal Care: MCTs are also being studied as part of nutritional support for preterm infants[4].

These ongoing studies highlight the potential for MCTs to play an increasingly important role in various medical treatments and nutritional support strategies.

Trial Focus Patient Population MCT Use Primary Outcome
Parenteral Nutrition Timing Major Emergency Abdominal Surgery Patients Part of SmofKabiven solution Rate of postoperative infections
Uremic Toxin Removal Chronic Hemodialysis Patients Medialipide infusion during dialysis Clearance of p-Cresyl sulfate
Sedation for LISA Procedure Preterm Infants with Respiratory Distress Syndrome Part of parenteral nutrition (background treatment) Need for mechanical ventilation within 72 hours

Ongoing Clinical Trials on Triglycerides, Medium Chain

  • A study comparing medium-chain triglycerides and sodium chloride infusions during hemodialysis to improve toxin removal in patients with chronic kidney disease

    Recruiting

    2 1 1 1
    France
  • Study on Nutrition Methods and Muscle Loss After Esophagectomy Using SmofKabiven and Drug Combination for Patients Recovering from Esophageal Surgery

    Not yet recruiting

    3 1 1 1
    Investigated diseases:
    Denmark
  • Study on the Effects of Propofol Sedation in Preterm Babies with Respiratory Distress Syndrome During LISA Procedure

    Not recruiting

    3 1 1
    France
  • Study on Early vs. Delayed Supplementary Parenteral Nutrition with SmofKabiven for Patients After Major Emergency Abdominal Surgery

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Denmark

Glossary

  • Medium Chain Triglycerides (MCTs): A type of fat that is more easily digested and absorbed by the body compared to long chain triglycerides. MCTs are being studied for their potential benefits in various medical conditions.
  • Parenteral Nutrition: A method of feeding that bypasses the gastrointestinal tract and provides nutrients directly into the bloodstream through an intravenous (IV) line.
  • SmofKabiven: A parenteral nutrition product containing a mixture of fats (including MCTs), amino acids, glucose, and other nutrients used to provide nutrition to patients who cannot eat normally.
  • Hemodialysis: A treatment for kidney failure that uses a machine to filter waste products from the blood outside the body.
  • Uremic Toxins: Harmful substances that accumulate in the blood when the kidneys are not functioning properly. These toxins are normally removed by healthy kidneys.
  • LISA (Less Invasive Surfactant Administration): A procedure used in premature infants to deliver surfactant (a substance that helps keep lung air sacs open) directly into the lungs without the need for intubation.
  • Respiratory Distress Syndrome: A breathing disorder that affects newborns, especially those born prematurely, due to a lack of surfactant in their lungs.
  • Propofol: A short-acting medication used for induction and maintenance of general anesthesia and sedation in clinical procedures.
  • Cachexia: A complex metabolic syndrome associated with underlying illness and characterized by loss of muscle with or without loss of fat mass.
  • Oesophagectomy: A surgical procedure to remove part or all of the esophagus, typically performed to treat esophageal cancer.

References

  1. http://clinicaltrials.eu/trial/study-on-improving-dialysis-for-chronic-kidney-disease-patients-using-medium-chain-triglycerides-and-soya-oil-compared-to-sodium-chloride/
  2. http://clinicaltrials.eu/trial/study-on-early-vs-delayed-supplementary-parenteral-nutrition-with-smofkabiven-for-patients-after-major-emergency-abdominal-surgery/
  3. http://clinicaltrials.eu/trial/study-on-nutrition-methods-and-muscle-loss-after-esophagectomy-using-smofkabiven-and-drug-combination-for-patients-recovering-from-esophageal-surgery/
  4. http://clinicaltrials.eu/trial/study-on-the-effects-of-propofol-sedation-in-preterm-babies-with-respiratory-distress-syndrome-during-lisa-procedure/